Article thumbnail

Ambulatory blood pressure in hypertensive patients with left ventricular hypertrophy: efficacy of first-line combination perindopril/indapamide therapy

By Roland Asmar, Juan Garcia-Puig, Philippe Gosse, Yuri A Karpov, Peter Wilhem De Leeuw, Dieter Magometschniggs, Lajos Matos and Roland Schmieder
Topics: Original Research
Publisher: Dove Medical Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). A diagnosis of left ventricular hypertrophy on ECG is associated with a high cardiovascular risk: fi ndings from a 40- to 69-year-old cohort in general practice. Fam Pract,
  2. (2005). A home blood pressure monitoring study comparing the antihypertensive effi cacy of two angiotensin II receptor antagonist fi xed combinations.
  3. (2003). A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
  4. (1995). Ambulatory blood pressure and left ventricular changes during antihypertensive treatment: Perindopril versus Isradipine.
  5. (2001). Antihypertensive effi cacy and tolerability of low-dose perindopril/indapamide combination compared with losartan in the treatment of essential hypertension.
  6. (2003). Effect of low-dose perindopril/indapamide on albuminuria in diabetes: preterax in albuminuria regression:
  7. (1998). Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial.
  8. (2002). Effi cacy of very low dose perindopril 2 mg/indapamide 0.625 mg combination on left ventricular hypertrophy in hypertensive patients: the P.I.C.X.E.L. study rationale and design.
  9. (1999). Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study.
  10. (2000). Long-term effi cacy of a new, fi xed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as fi rst-line therapy in elderly hypertensive patients.
  11. (2004). Meta-analysis suggests regression of left ventricular hypertrophy during antihypertensive treatment is linked to reduced risk of cardiovascular disease. Evid Based Cardiovasc Med,
  12. (1999). Optimisation of antihypertensive treatment by crossover rotation of four major classes.
  13. (2005). Perindopril/indapamide combination more effective than enalapril in reducing blood pressure and left ventricular mass: the PICXEL study.
  14. (2000). Prognostic signifi cance of blood pressure and heart rate variabilities: the Ohasama study.
  15. (1993). Prognostic value of 24-hour blood pressure variability.
  16. (1999). Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial.
  17. (2004). Regression of left ventricular mass in hypertensive patients treated with perindopril/ indapamide as a fi rst-line combination: the REASON echocardiography study.
  18. (1991). Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension.
  19. (1992). Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies.
  20. (2006). Role of aldosterone in left ventricular hypertrophy in hypertension.
  21. (2004). Twenty-four-hour ambulatory blood pressure monitoring effi cacy of perindopril/indapamide fi rst-line combination in hypertensive patients: the REASON study.
  22. (1986). Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men.